Table 1 Baseline characteristics of study participants
Characteristics | Control group | AML group |
|---|---|---|
Age (years) (mean ± SD) | 46.9 ± 6.3 | 53.4 ± 12.9 |
Gender (male/female) | 7/8 | 24/36 |
FAB classification | ||
M0 | – | 8 patients |
M1–M2 | – | 4 patients |
M2 | – | 12 patients |
M3 | – | 12 patients |
M4 | – | 24 patients |
Prognosis according to cytogenetic studies (favorable/unfavorable) | – | 20/40 |